NCT01728038

Brief Summary

An estimated 6.6 million parents who smoke visit pediatric emergency departments (PED) annually. Up to 50% of these parental smokers are from low-income, racially/ethnically diverse households in which a variety of tobacco-related disparities (TRD) exist for both the parents and their children. The PED is an ideal setting in which to address these disparities, which include differences in tobacco use, pediatric second hand smoke exposure (SHSe), quit rates, access to cessation resources, and morbidity such as cancer. The team has conducted the only two small-scale randomized control trials (RCTs) investigating the efficacy of providing smoking cessation counseling to parents in the PED setting. This previous research indicates that parental smokers who visit the PED are aware of the pediatric effects of SHSe, motivated to quit, eager to receive cessation counseling in this setting, and show trends towards quitting. Parents with children who have a SHSe-related illness will have higher prolonged abstinence and point prevalence cessation rates, higher motivation to quit, greater number of quit attempts, and lower child SHSe compared to those parents who have a child with a non-SHSe-related illness at baseline.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
230

participants targeted

Target at P75+ for not_applicable asthma

Timeline
Completed

Started Mar 2012

Longer than P75 for not_applicable asthma

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2012

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

November 13, 2012

Completed
3 days until next milestone

First Posted

Study publicly available on registry

November 16, 2012

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2014

Completed
1.7 years until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2016

Completed
Last Updated

August 30, 2017

Status Verified

August 1, 2017

Enrollment Period

2.3 years

First QC Date

November 13, 2012

Last Update Submit

August 29, 2017

Conditions

Keywords

BronchiolitisCoughEar InfectionRespiratory InfectionWheezing

Outcome Measures

Primary Outcomes (1)

  • Parents who report that they have not smoked in the past seven (7) days, and their verbal response is verified by a carbon monoxide test.

    Approximately 2 years

Study Arms (1)

Cessation Counseling

EXPERIMENTAL

Parental smokers will be given a brief cessation intervention consisting of counseling, nicotine replacement therapy and Quitline connection.

Behavioral: Cessation Counseling

Interventions

Parental Smokers will be given brief cessation counseling, nicotine replacement therapy and Quitline connection.

Cessation Counseling

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Hospital personnel: PED medical director, Chief of Staff, Chairman of Pediatrics, quality systems specialists, informational technology specialists, PED physicians, and PED registered nurses.

You may not qualify if:

  • Non-hospital personnel
  • Phase 2: Parental smokers who bring their children to the pediatric emergency department will be given brief smoking cessation counseling which includes advice on quitting, nicotine replacement therapy vouchers and direct Quitline connection.
  • Parent/Legal Guardian (18 years or older), who are tobacco users, accompanying a child (0 to 18 years old) being treated in the PED with a non-urgent complaint/condition.
  • Parent/Legal Guardian who is only a tobacco chewer.
  • Parent/Legal Guardian who is enrolled in a smoking cessation program.
  • Parent/Legal Guardian who is using Nicotine Replacement Therapy (NRT) or other cessation treatment.
  • Parent/Legal Guardian who is moving within 8 months after enrollment.
  • Phase 3: The same PED-based SBIRT cessation intervention will be given to these parental smokers as in Phase 2. However, parents will also be asked if they agree to have their child participate in saliva sample collection at baseline and at one month. Parents will also be asked if their child's leftover saliva can be stored for future research.
  • Parent/Legal Guardian (18 years or older), who are tobacco users, accompanying a child (0 to 5 years old) being treated in the PED with a non-urgent second hand smoke exposure related complaint/condition.
  • Parent/Legal Guardian who is only a tobacco chewer.
  • Parent/Legal Guardian who is enrolled in a smoking cessation program.
  • Parent/Legal Guardian who is using Nicotine Replacement Therapy (NRT) or other cessation treatment.
  • Parent/Legal Guardian who is moving within 8 months after enrollment
  • Parent/Legal Guardian who does not speak or read English

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cincinnati Children's Hospital Medical Center

Cincinnati, Ohio, 45229, United States

Location

Related Publications (2)

  • Mahabee-Gittens EM, Stone L, Gordon JS. Pediatric emergency department is a promising venue for adult tobacco cessation interventions. Nicotine Tob Res. 2013 Oct;15(10):1792-3. doi: 10.1093/ntr/ntt069. Epub 2013 May 24. No abstract available.

  • Mahabee-Gittens EM, Khoury JC, Ho M, Stone L, Gordon JS. A smoking cessation intervention for low-income smokers in the ED. Am J Emerg Med. 2015 Aug;33(8):1056-61. doi: 10.1016/j.ajem.2015.04.058. Epub 2015 May 2.

MeSH Terms

Conditions

AsthmaBronchiolitisCoughOtitisRespiratory Tract InfectionsRespiratory Sounds

Condition Hierarchy (Ancestors)

Bronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveLung DiseasesRespiratory HypersensitivityHypersensitivity, ImmediateHypersensitivityImmune System DiseasesBronchitisInfectionsRespiration DisordersSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and SymptomsEar DiseasesOtorhinolaryngologic Diseases

Study Officials

  • Esther M. Mahabee-Gittens, MD, MS

    Professor

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 13, 2012

First Posted

November 16, 2012

Study Start

March 1, 2012

Primary Completion

July 1, 2014

Study Completion

March 1, 2016

Last Updated

August 30, 2017

Record last verified: 2017-08

Locations